Article
Targeting Class IIa HDACs: Insights from Phenotypes and Inhibitors.
Current medicinal chemistry - 1 Jan 2021
Liu Ligong, Dong Lilong, Bourguet Erika, Fairlie David P
Abstract excerpt
This review summarizes key literature defining the phenotypes of individual class IIa HDAC proteins and compounds that selectively target their enzymatic catalytic domain (CD). The focus is on the effects of class IIa HDACs in physiological and pathological conditions, both in vitro and in vivo, and on their mode of action in regulating genes, upstream proteins and signaling pathways. Phenotype studies further...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
